Kurota, Y.; Takeda, Y.; Ichiyanagi, O.; Saitoh, S.; Ito, H.; Naito, S.; Asao, H.; Tsuchiya, N.
Hemoglobin β Expression Is Associated with Poor Prognosis in Clear Cell Renal Cell Carcinoma. Biomedicines 2023, 11, 1330.
https://doi.org/10.3390/biomedicines11051330
AMA Style
Kurota Y, Takeda Y, Ichiyanagi O, Saitoh S, Ito H, Naito S, Asao H, Tsuchiya N.
Hemoglobin β Expression Is Associated with Poor Prognosis in Clear Cell Renal Cell Carcinoma. Biomedicines. 2023; 11(5):1330.
https://doi.org/10.3390/biomedicines11051330
Chicago/Turabian Style
Kurota, Yuta, Yuji Takeda, Osamu Ichiyanagi, Shinichi Saitoh, Hiromi Ito, Sei Naito, Hironobu Asao, and Norihiko Tsuchiya.
2023. "Hemoglobin β Expression Is Associated with Poor Prognosis in Clear Cell Renal Cell Carcinoma" Biomedicines 11, no. 5: 1330.
https://doi.org/10.3390/biomedicines11051330
APA Style
Kurota, Y., Takeda, Y., Ichiyanagi, O., Saitoh, S., Ito, H., Naito, S., Asao, H., & Tsuchiya, N.
(2023). Hemoglobin β Expression Is Associated with Poor Prognosis in Clear Cell Renal Cell Carcinoma. Biomedicines, 11(5), 1330.
https://doi.org/10.3390/biomedicines11051330
